€63.66 ABI.BR stock Anheuser-Busch InBev EURONEXT 12 Feb 2026 earnings: what to watch

ABI.BR stock trades at €63.66 intraday as investors position ahead of Anheuser-Busch InBev SA/NV’s 12 Feb 2026 earnings release. We see a tight intraday range — day low €63.40 and day high €64.04 — with volume at 2,217,787 shares, above average. This earnings spotlight examines the key metrics investors will watch, the market context on EURONEXT in Europe, and how those figures could move price in the session. Meyka AI provides an independent, data-driven perspective to frame today’s trading and the near-term outlook.

ABI.BR stock: Earnings snapshot

Anheuser-Busch InBev (ABI.BR) is scheduled to report results on 12 Feb 2026; the company lists an earnings announcement time of 16:40 UTC. We expect management commentary on volumes, pricing and cost savings to drive the print.

Investors should watch revenue and operating margin beats versus consensus, and any update on free cash flow given ABI.BR’s leverage profile and dividend policy.

ABI.BR stock: What the numbers say

ABI.BR trades at €63.66 with a market cap of €126.05B and EPS of €2.53; the reported PE stands at 25.64 on the latest quote. Price sits well above the 50-day average (€56.87) and 200-day average (€55.87), signalling recent strength.

Revenue trends are mixed: trailing twelve months revenue near $58.61B with low single-digit growth. Use of working capital and payables dynamics remain important; days payable outstanding is high at 246.90 days, which anchors working capital performance.

Meyka AI rates ABI.BR with a score out of 100

Meyka AI rates ABI.BR with a score out of 100: Score 71.18/100 | Grade B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Note the platform-level context: companyRating data shows a separate rating of C (Sell) from a different model dated 11 Feb 2026, highlighting differing signals between valuation screens and growth/forecast models. These grades are informational only and not financial advice.

Technical and trading snapshot for ABI.BR stock

Intraday action shows rel. volume 1.50 with current volume 2,217,787 versus avg 1,637,059, indicating heavier trading. RSI near 51.61 implies neutral momentum and MACD histogram is marginally negative.

Short-term support sits near €56.87 (50-day MA) and resistance near the year high €64.86. Traders will also watch OBV and MFI (MFI 80.68, signalling short-term overbought conditions).

Risks and opportunities in the ABI.BR stock earnings

Key risks: net debt to EBITDA at 2.91x, debt to equity 0.94, and interest coverage 3.74x leave ABI.BR exposed to higher rates and slower cash conversion if volumes soften. Dividend yield is modest at 1.24%, limiting income appeal for yield-focused investors.

Opportunities: strong brand portfolio across global markets, improving operating income growth (latest FY operating income growth 10.89%), and recent free cash flow improvements could support buybacks or dividend stability if trends continue. For background on revenue trends, see a recent revenue summary source.

ABI.BR stock outlook and analyst signals

Market signals are mixed: a third-party company rating shows C / Sell while our model grades the stock B+ / BUY, reflecting divergent views on leverage versus growth. Price momentum has delivered strong year-to-date gains of 19.23% and one-year gain of 32.94%.

Recent market headlines show Belgium market moves and ABI.BR gains; see coverage of local market action and stock performance on EURONEXT source. For details on the live quote and trading, view the Meyka AI stock page for ABI.BR ABI.BR on Meyka.

Final Thoughts

We see ABI.BR stock trading at €63.66 as an earnings-driven intraday setup. Near-term catalysts include volume, pricing disclosure, and guidance for 2026. Meyka AI’s forecast model projects a near-term monthly level of €67.93, which implies an upside of 6.71% from the current price, and a quarterly model level of €59.06 implying a downside of -7.23%. The one-year model projects €55.84, implying -12.29% downside. These levels frame a balanced range: the market is pricing premium growth but also reflects leverage and margin risk.

Our view: mixed signals from leverage metrics (net debt/EBITDA 2.91x) and a separate institutional rating of C / Sell contrast with a Meyka grade B+ (BUY) driven by solid brand positions and improving operating income. Use earnings to reassess exposure: positive surprises could re-rate ABI.BR toward the monthly forecast, while weak cash flow or guidance could push price toward the yearly projection. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.